NCT07474220 Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
| NCT ID | NCT07474220 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fu Jen Catholic University |
| Condition | Chronic Obstructive Pulmonary Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2026-06-29 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2026-06-29 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.
Eligibility Criteria
Inclusion Criteria: * pre-COPD or COPD stages I-IV as per the 2023 GOLD guidelines (case group) * healthy individuals without chronic diseases or major medical conditions Exclusion Criteria: * diagnosed with neuromuscular diseases * experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months * assessed by a physician to have severe malnutrition or a significantly low BMI * continuously taking folic acid supplements * willing to receive or have already received self-paid nutrition clinic services at this hospital
Contact & Investigator
Ke-Yun Chao, PhD
PRINCIPAL INVESTIGATOR
Fu Jen Catholic University
Frequently Asked Questions
Who can join the NCT07474220 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07474220 currently recruiting?
Yes, NCT07474220 is actively recruiting participants. Contact the research team at ck_qq@hotmail.com for enrollment information.
Where is the NCT07474220 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan, New Taipei City, Taiwan.
Who is sponsoring the NCT07474220 clinical trial?
NCT07474220 is sponsored by Fu Jen Catholic University. The principal investigator is Ke-Yun Chao, PhD at Fu Jen Catholic University. The trial plans to enroll 180 participants.